UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I Nai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties

Journal of medicinal chemistry, 2016-10, Vol.59 (19), p.9005-9017

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug Annotations Series Change in Guidelines

Journal of medicinal chemistry, 2019-03, Vol.62 (5), p.2217-2217

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists

The Journal of pharmacology and experimental therapeutics, 2001-07, Vol.298 (1), p.209

2001

Link zum Volltext

Verfügbarkeit prüfen

Using Patchxpress to Screen Blockers of the Cardiac Sodium Channel (Nav1.5) for Effects on Late INA, Peak INA, and Channel Kinetics

Biophysical journal, 2010-01, Vol.98 (3), p.113a-113a

2010

Link zum Volltext

Verfügbarkeit prüfen

Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF)

Current topics in medicinal chemistry, 2004, Vol.4 (8), p.839

2004

Link zum Volltext

Verfügbarkeit prüfen

CVT-4325: A Potent Fatty Acid Oxidation Inhibitor with Favorable Oral Bioavailability

ChemInform, 2005-04, Vol.36 (15), p.no-no

2005

Link zum Volltext

Verfügbarkeit prüfen

Structure‐Affinity Relationships of the Affinity of 2‐Pyrazolyl Adenosine Analogues for the Adenosine A 2A Receptor

ChemInform, 2003-02, Vol.34 (8)

2003

Link zum Volltext

Verfügbarkeit prüfen

A1 adenosine receptor agonists and their potential therapeutic applications

Expert opinion on investigational drugs, 2008-12, Vol.17 (12), p.1901-1910

2008

Link zum Volltext

Verfügbarkeit prüfen

A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias

The Journal of pharmacology and experimental therapeutics, 2013-01, Vol.344 (1), p.23

2013

Link zum Volltext

Verfügbarkeit prüfen

Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B

Journal of medicinal chemistry, 2020-09, Vol.63 (18), p.10188-10203

2020

Link zum Volltext

Verfügbarkeit prüfen

The Drug Annotations Series

Journal of medicinal chemistry, 2013-09, Vol.56 (17), p.6541-6541

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecule Evoluator CIDRUX BV, Park Oosterspaarn 6, 2036 MB Haarlem, The Netherlands. www. cidrux.com. See Web site for pricing information

Journal of the American Chemical Society, 2007-10, Vol.129 (41), p.12586-12586

Zablocki, Jeff

2007

Link zum Volltext

Verfügbarkeit prüfen

Marked difference in saxitoxin and tetrodoxin affinity for the human nociceptive voltage-gated sodium channel (Naᵥ1.7)

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (44), p.18102-18107

2012

Link zum Volltext

Verfügbarkeit prüfen

A1 adenosine receptor antagonists, agonists, and allosteric enhancers

Handbook of experimental pharmacology, 2009 (193), p.25

2009

Link zum Volltext

Verfügbarkeit prüfen

The novel late Na+ current inhibitor, GS‐6615 (eleclazine) and its anti‐arrhythmic effects in rabbit isolated heart preparations

British journal of pharmacology, 2016-11, Vol.173 (21), p.3088-3098

2016

Link zum Volltext

Verfügbarkeit prüfen

How Can Rates of Prostate-Specific Antigen Screening Be Reduced in Men Aged 80 and Older?

Journal of the American Geriatrics Society (JAGS), 2010-04, Vol.58 (4), p.757-759

2010

Link zum Volltext

Verfügbarkeit prüfen

Preface: special issue on medicinal chemistry of purines

Purinergic signalling, 2009-03, Vol.5 (1), p.1-1

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis

Nature Medicine, 2010-09, Vol.16 (9), p.1024-1028

2010

Link zum Volltext

Verfügbarkeit prüfen

A 1 adenosine receptor agonists and their potential therapeutic applications

Expert opinion on investigational drugs, 2008-12, Vol.17 (12), p.1901-1910

2008

Link zum Volltext

Verfügbarkeit prüfen

The novel late Na super(+) current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparations

British journal of pharmacology, 2016-11, Vol.173 (21), p.3088-3098

2016

Link zum Volltext

Verfügbarkeit prüfen

Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates

Purinergic signalling, 2009, Vol.5 (1), p.21-29

2009

Link zum Volltext

Verfügbarkeit prüfen

Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates

Purinergic signalling, 2009-03, Vol.5 (1), p.21-29

2009

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

Journal of medicinal chemistry, 2008-04, Vol.51 (7), p.2267-2278

2008

Link zum Volltext

Verfügbarkeit prüfen

Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (Nav1.7)

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (44), p.18102-18107

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBioorganic & Medicinal Chemistry Letters

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(43)
Buchkapitel
(2)

Sprache

Englisch
(44)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I Nai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties

Drug Annotations Series Change in Guidelines

Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists

Using Patchxpress to Screen Blockers of the Cardiac Sodium Channel (Nav1.5) for Effects on Late INA, Peak INA, and Channel Kinetics

Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF)

CVT-4325: A Potent Fatty Acid Oxidation Inhibitor with Favorable Oral Bioavailability

Structure‐Affinity Relationships of the Affinity of 2‐Pyrazolyl Adenosine Analogues for the Adenosine A 2A Receptor

A1 adenosine receptor agonists and their potential therapeutic applications

A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias

Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B

The Drug Annotations Series

Molecule Evoluator CIDRUX BV, Park Oosterspaarn 6, 2036 MB Haarlem, The Netherlands. www. cidrux.com. See Web site for pricing information

Marked difference in saxitoxin and tetrodoxin affinity for the human nociceptive voltage-gated sodium channel (Naᵥ1.7)

A1 adenosine receptor antagonists, agonists, and allosteric enhancers

The novel late Na+ current inhibitor, GS‐6615 (eleclazine) and its anti‐arrhythmic effects in rabbit isolated heart preparations

How Can Rates of Prostate-Specific Antigen Screening Be Reduced in Men Aged 80 and Older?

Preface: special issue on medicinal chemistry of purines

Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis

Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor

A 1 adenosine receptor agonists and their potential therapeutic applications

The novel late Na super(+) current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparations

Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates

Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates

Discovery of a Novel A2B Adenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases

Marked difference in saxitoxin and tetrodotoxin affinity for the human nociceptive voltage-gated sodium channel (Nav1.7)

Aktive Filter

Suchergebnisse filtern